Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
97.32
+1.10 (1.14%)
At close: Oct 3, 2025, 4:00 PM EDT
97.67
+0.35 (0.36%)
After-hours: Oct 3, 2025, 7:55 PM EDT
Boston Scientific Revenue
Boston Scientific had revenue of $5.06B in the quarter ending June 30, 2025, with 22.84% growth. This brings the company's revenue in the last twelve months to $18.49B, up 21.44% year-over-year. In the year 2024, Boston Scientific had annual revenue of $16.75B with 17.61% growth.
Revenue (ttm)
$18.49B
Revenue Growth
+21.44%
P/S Ratio
7.77
Revenue / Employee
$348,943
Employees
53,000
Market Cap
144.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 16.75B | 2.51B | 17.61% |
| Dec 31, 2023 | 14.24B | 1.56B | 12.29% |
| Dec 31, 2022 | 12.68B | 794.00M | 6.68% |
| Dec 31, 2021 | 11.89B | 1.98B | 19.92% |
| Dec 31, 2020 | 9.91B | -822.00M | -7.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
BSX News
- 3 days ago - Boston Scientific Corporation (BSX) Analyst/Investor Day Transcript - Seeking Alpha
- 15 days ago - Top 3 Health Care Stocks That May Explode In September - Benzinga
- 4 weeks ago - Boston Scientific announces 2025 Investor Day meeting and conference call discussing third quarter 2025 results - PRNewsWire
- 5 weeks ago - 8 Growth Stocks to Buy That Aren't Technology. What Makes Them Worth It. - Barrons
- 2 months ago - Boston Scientific Corporation Is Expensive But Worth It - Seeking Alpha
- 2 months ago - Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025 - Seeking Alpha
- 2 months ago - Former FDA Director and Boston Scientific Leaders Join Keyron Ahead of Human Trials of First Device with Metabolic Surgery-Like Results Without Incisions - Business Wire
- 2 months ago - 10 stocks favored to gain up to 30% in a sector that has missed this year's rally - Market Watch